Winning $600 million in new business with a major data-center operator will support Generac expanding manufacturing capacity at its plants in Sussex, Beaver Dam, Oshkosh and elsewhere.

As companies rethink where they operate, how they engage customers and what motivates employees to show up in person, markets ...

Ghostwriter used Prometheus lures since spring 2026 to target Ukraine agencies, enabling malware delivery and data theft.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Grok, the AI chatbot on Elon Musk’s social media platform X, is limiting image generation and editing capabilities to paying subscribers amid a global outcry from officials and users over the tool ...